We are motivated by science and inspired by patients.
Who we are
We are a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious.
BMS in Europe
Our European workforce of 6,800 people is defining what is possible for the future of science and the patients we serve.
What we do
We collaborate with stakeholders to design a policy environment that spurs the discovery, development, manufacture and adoption of new medicines.
We ask ourselves: who are you working for? Patients.
Since 1887, we have powered positive change for patients in Europe and around the world.
We innovate across oncology, hematology, immunology, neuroscience and cardiovascular diseases.
We have one of the most diversified portfolios and pipelines in the industry.
Our differentiated research platforms, including cell therapy, targeted protein degradation and radiopharmaceuticals, are core to our work.
Our European investments, whether in manufacturing sites, commercial teams or clinical trials, are part of a global story of innovation excellence.
